Physicians' Academy for Cardiovascular Education

Atrial fibrillation

Oral anticoagulant monotherapy reduces bleeding in AF patients after TAVI

3' education - Mar. 30, 2020 - Dr. Jur ten Berg, MD, PhD - ACC 2020

Challenges in prescribing DOACs for stroke prevention in AF

5' education - Mar. 2, 2020 - Prof. Freek Verheugt and John Eikelboom

Smartphone-based AF screening in the general population

5' education - Oct. 28, 2019 - Paris, France - Tine Proesmans

Clear results with NOAC monotherapy in patients with CAD and AF

3' education - Sep. 2, 2019 - Prof. Freek Verheugt

Better outcomes in patients with AF and ACS/PCI with NOAC vs. VKA and when dropping aspirin

3' education - Mar. 17, 2019 - New Orleans, LA, USA - John Alexander, MD

Proof-of-concept study shows 84% true AF in those with irregular pulse detected with smartwatch

3' education - Mar. 16, 2019 - New Orleans, LA, USA - Michael Valentine, MD

Population screening for atrial fibrillation with a smartphone

10' education - Aug. 26, 2018 - Munich, Germany - Prof. dr. Pieter Vandervoort - Genk, Belgium

Atrial fibrillation & HFpEF: Novel device and therapeutic approaches

10' education - May 27, 2018 - ESC Heart Failure 2018, Vienna - Dipak Kotecha - Birmingham, UK - Online CME

Considerations on antithrombotic treatment of VTE and AF patients

10' education - Mar. 8, 2018 - Prof. Menno Huisman and dr. Alexander Cohen

Neurotoxin injection did not prevent the common complication of AF after cardiac surgery

3' education - Nov. 15, 2017 - AHA 2017 - Anaheim, CA, USA - Nathan Waldron, MD - Durham, NC, USA.

Initiating digoxin in AF patients associated with early hazard of sudden death

3' education - Mar. 19, 2017 - ACC 2017, Washington, DC, USA - Dr. Renato Lopes

Tailoring oral anticoagulation in elderly patients with AF

3' education - Nov. 12, 2016 - New Orleans, LA, USA - Christopher B. Granger, MD (Durham, NC, USA)

Outstanding questions and ongoing studies on the use of NOACs

3' education - Oct. 7, 2016 - Berg en Dal, The Netherlands - Prof. Chris Granger, MD (Durham, NC, USA)

Oral anticoagulation in daily clinical practice in varous patient populations

10' education - Oct. 6, 2016 - The Netherlands - Prof. Chris Granger, MD (Durham, NC, USA) and Marc Brouwer, MD (Nijmegen, The Netherlands)

Inadequate anticoagulant treatment for stroke prevention in atrial fibrillation

3' education - Apr. 1, 2016 - VBWG Meeting at ACC 2016, Chicago, IL, USA - Christian T. Ruff, MD - Boston, MA, USA
##SCROLLER_ITEMS_FULL_TITLE##

Where are we with HF patients with AF?

3' education - Oct. 31, 2015 - HF Summit, Barcelona, Spain - Dr. Dipak Kotecha
##SCROLLER_ITEMS_FULL_TITLE##

Translating new clinical trial data of DOACs for stroke prevention into clinical practice

3' education - Mar. 30, 2014 - VBWG at ACC - Michael Ezekowitz MD, PhD

Oral anticoagulant monotherapy reduces bleeding in AF patients after TAVI

3' education - Mar. 30, 2020 - Dr. Jur ten Berg, MD, PhD - ACC 2020
Anticoagulant monotherapy reduced bleeding compared to anticoagulant therapy plus clopidogrel, without increasing ischemic events in AF patients undergoing TAVI.

ACC 2020 Oral anticoagulant monotherapy reduced bleeding compared to anticoagulant therapy plus clopidogrel, without increasing ischemic events in AF patients undergoing TAVI.

OAC alone reduces bleeding in AF patients after TAVI

News - Mar. 30, 2020
The POPular TAVI trial showed that OAC alone compared to OAC plus clopidogrel reduced bleeding and did not increase thrombotic events in AF patients undergoing TAVI.

ACC 2020 The POPular TAVI trial showed that OAC alone compared to OAC plus clopidogrel reduced bleeding and did not increase thrombotic events in AF patients undergoing TAVI.

Integrated care for elderly AF patients can be safely organized in primary care

Literature - Mar. 9, 2020 - Van den Dries CJ, Van Doorn S, Rutten FH et al., - Eur Heart J. 2020.
This cluster randomized, non-inferiority trial showed that integrated care for elderly AF patients in a primary care setting led to a 45% reduction in all-cause mortality compared with usual care.

This cluster randomized, non-inferiority trial showed that integrated care for elderly AF patients in a primary care setting led to a 45% reduction in all-cause mortality compared with usual care.

Challenges in prescribing DOACs for stroke prevention in AF

5' education - Mar. 2, 2020 - Prof. Freek Verheugt and John Eikelboom
Although DOACs are safe and effective in AF patients, there are remaining challenges in prescribing DOACs. Freek Verheugt and John Eikelboom discuss 3 topics: underdosing, underuse and antidotes.

Although DOACs are safe and effective in AF patients, there are remaining challenges in prescribing DOACs. Freek Verheugt and John Eikelboom discuss 3 topics: underdosing, underuse and antidotes. With poll

SGLT2i reduces atrial fibrillation and atrial flutter in T2DM

Literature - Feb. 17, 2020 - Zelniker TA et al. - Circulation 2020

The SGLT2 inhibitor dapagliflozin reduced time to first event of atrial fibrillation and atrial flutter as well as total events in T2DM patients, shown in a post-hoc analysis of the DECLARE-TIMI 58 trial.

Less AF recurrence with combination of catheter ablation and renal denervation

Literature - Jan. 28, 2020 - Steinberg JS, et al. - JAMA. 2020

The randomized ERADICATE-AF trial demonstrated that a combination of catheter ablation and renal denervation in patients with paroxysmal AF and hypertension resulted in higher likelihood of freedom from AF compared to catheter ablation alone.

Previously unknown AF prevalent, but AF burden low in at-risk elderly persons with implanted loop recorder

Literature - Dec. 9, 2019 - Diederichsen SZ et al., - J Am Coll Cardiol. 2019

The LOOP study used implanted loop recorders to detect previously unknown AF and determined AF burden, progression and symptoms in in elderly patients from the general population with CV risk factors.

Rate, trends and predictors of early mortality after AF ablation

Literature - Nov. 7, 2019 - Cheng EP, et al. - J Am Coll Cardiol 2019

In a real-world cohort including data of >60,000 AF ablation procedures performed between 2010-2015, early mortality rate was 0.46%. Strongest predictors for early mortality were procedural complications, CHF and low AF ablation hospital volume.

Lower risk of osteoporotic fractures in AF patients with DOAC vs. VKA treatment

Literature - Oct. 29, 2019 - Binding C, et al. - J Am Coll Cardiol 2019

In a Danish cohort study of nonvalvular AF patients, DOAC use was associated with a lower risk of osteoporotic fractures compared to VKA treatment.

Smartphone-based AF screening in the general population

5' education - Oct. 28, 2019 - Paris, France - Tine Proesmans
Tine Proesmans explains how screening for AF can be done in the general population using a smartphone and shares results of the DIGITAL-AF II study.

CSI Paris Tine Proesmans explains how screening for AF can be done in the general population using a smartphone and shares results of the DIGITAL-AF II study.

Ischemic outcomes with antithrombotic regimes in AF patients with ACS or undergoing PCI

Literature - Oct. 14, 2019 - Potpara TS, et al. - Europace 2019

A meta-analysis of RE-DUAL PCI, PIONEER AF-PCI and AUGUSTUS compared NOAC- and VKA-based regimens and antithrombotic therapies with and without aspirin for ischemic outcomes and CV and total mortality.

Parental smoking increases AF risk in offspring

Literature - Oct. 10, 2019 - Groh CA et al., - J Am Coll Cardiol 2019

Data of the Framingham Original and Offspring Cohorts show that parental smoking during childhood is associated with a higher AF risk, partly because offspring show higher propensity of smoking.